Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
1 clinical trials · Condition
◉ Watch Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
| Record | Firm | Date |
|---|---|---|
| BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE) (NCT05474885) | iCell Gene Therapeutics | 2022-04-01 |
Track Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) automatically
Every clearance here is in the API, with alerts when new ones post.